Navigation Links
Advanced Life Sciences Cancels Annual Meeting of Shareholders
Date:5/20/2011

CHICAGO, May 20, 2011 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS.OB), announced today that it has cancelled its Annual Meeting of Shareholders, which was previously scheduled to take place on Tuesday, May 24, 2011.  

(Logo:  http://photos.prnewswire.com/prnh/20080218/ALSLOGO)

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases.  On May 5, 2011, Advanced Life Sciences announced that it had suspended operations and terminated its staff due to its severe lack of liquidity.


'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)...  The Mesothelioma Victims Center is incredibly passionate ... the best possible compensation, and they are also extremely ... cancer caused by exposure to asbestos or their ... treatment options such as a recent possible medical breakthrough. ... Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)...   InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or ... today announced that its CGuard TM Embolic Prevention System ... Piotr Musialek , at the EuroPCR conference ... . PARADIGM, an investigator-initiated P rospective evaluation ... D revascularization I n symptomatic and increased-risk asymptomatic ...
(Date:5/22/2015)... , May 22, 2015  In a sweeping ... the U.S., T1D Exchange researchers conclude that ... type 1 diabetes across all age groups, but especially ... most up-to-date picture of diabetes treatment, underscoring the need ... and technologies that can help type 1 patients achieve ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... Oct. 31, 2011 Menicon Holdings BV and Eye ... a France-based independent ophthalmic group, announced on October 31 ... to market the SOLO-care (R) contact lens solutions range ... Canada. The agreement will enable Menicon to ...
... 28, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... States District Court for the District of Massachusetts ... request for a preliminary injunction preventing Watson and ... Enoxaparin Sodium Injection, a generic equivalent to Sanofi-aventis, ...
Cached Medicine Technology:Menicon to Market Eye Shelter's SOLO-care (R) Contact Lens Solution Range in Europe and Canada 2Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX® 2Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX® 3
(Date:5/24/2015)... A report out just last ... best option for avoiding cardiovascular disease is exercise and ... the single most powerful predictor of death and survival, ... and family history of premature death -- a finding ... lung fitness. , The Importance of Cardiovascular Screening , ...
(Date:5/23/2015)... On Wednesday, May 20, 2015, CareFirst ... been the target of a sophisticated cyberattack,” and that ... ongoing Information Technology (IT) security efforts in the wake ... most notable attack on health insurers was reported in ... second largest health insurer, revealed that they had suffered ...
(Date:5/23/2015)... 2015 Add High-Quality prismatic refractions into footage ... , It's as simple as dragging and dropping footage into ... for full effect. , Including over 80 stunning flares, ... sensors making this the ultimate bundle for adding prismatic refractions ... this package are movie files designed for Final Cut Pro ...
(Date:5/22/2015)... Mountain Point Medical Center, a campus of ... on Friday, May 29, 2015 at 11 a.m., followed by ... new medical center, set to officially open on June 1, ... 84043. , “The opening of Mountain Point Medical Center ... County community,” said Kent Loosle, CEO of Mountain Point Medical ...
(Date:5/22/2015)... 22, 2015 Combination therapy, or ... for chronic obstructive pulmonary disorder (COPD) as the ... AstraZeneca plc as well as Germany’s Boehringer Ingelheim ... position. But will market payers, clinicians and patients ... products to completely new ones? , In spite ...
Breaking Medicine News(10 mins):Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2
... costs by an average 1% over two years ... wellness initiatives including smoker surcharges.TROY, Mich., May 18 ... brokerage/consulting firm, today released the results of its ... survey compares health benefits and trends for the ...
... Myeloma Research Foundation (MMRF) announced today a collaboration with ... uncover the molecular changes underlying multiple myeloma by whole ... provide both patient samples for analysis as well as ... will be put in the public domain. , "We ...
... abreast of the most important osteoporosis-related research? Progress ... the International Osteoporosis Foundation (IOF) on www.iofbonehealth.org/pio ... preceding three to four months. The journal is edited ... of the University of Melbourne, Australia. , ...
... SAINT PETERSBURG, Fla. , May 18 ... competitive $1.28 billion Picture Archiving Communications Systems (PACS) ... Sullivan,s "Technology Leadership Award for Cardiovascular PACS" (CVPACS), ... by KLAS, Thinking Systems Corporation develops and markets ...
... Health Systems, Inc. (NYSE Amex: ADK ), an ... reported financial results for its first quarter of 2009. ... as compared to $5,992,542 for the same quarter in 2008, ... to improved occupancy at its assisted living communities, an increase ...
... California to volunteer in their communities INDIANAPOLIS, May ... blanket communities in the U.S. and across the globe as ... and energy to improve the health and well-being of their ... of Service.Last year, more than 20,000 Lilly employees from more ...
Cached Medicine News:Health News:McGraw Wentworth Mid-Market Group Benefits Survey Shows Health Care Costs Increasing at 6-Year Low of 5% 2Health News:McGraw Wentworth Mid-Market Group Benefits Survey Shows Health Care Costs Increasing at 6-Year Low of 5% 3Health News:MMRF and the Broad Institute to perform whole genome sequencing of multiple myeloma samples 2Health News:Thinking Systems to Showcase the Company's Upgraded ThinkingPACS(TM) and ThinkingRIS(TM) Solutions 2Health News:AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results 2Health News:AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results 3Health News:AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results 4Health News:AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results 5Health News:AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results 6Health News:AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results 7Health News:AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results 8Health News:Lilly to Celebrate Second Annual Global Day of Service May 20 2Health News:Lilly to Celebrate Second Annual Global Day of Service May 20 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: